Anaphylaxis in children and adolescents: the European anaphylaxis registry, J Allergy Clin Immunol, vol.137, pp.1128-1165, 2016. ,
Epidemiology of allergic reactions to hymenoptera stings in Irish school children, Pediatr Allergy Immunol, vol.21, pp.1166-70, 2010. ,
EAACI guidelines on allergen immunotherapy: hymenoptera venom allergy, Allergy, vol.73, pp.744-64, 2018. ,
Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab, J Investig Allergol Clin Immunol, vol.19, pp.225-234, 2009. ,
Overcoming severe adverse reactions to venom immunotherapy using anti-IgE antibodies in combination with a high maintenance dose, Clin Exp Allergy, vol.47, pp.1631-1640, 2017. ,
Omalizumab: a useful tool for inducing tolerance to bee venom immunotherapy, Int J Immunopathol Pharmacol, vol.29, pp.726-734, 2016. ,
IgE-Api m 4 is useful for identifying a particular phenotype of bee venom allergy, J Investig Allergol Clin Immunol, vol.26, pp.355-61, 2016. ,
Failure of omalizumab treatment after recurrent systemic reactions to bee-venom immunotherapy, J Investig Allergol Clin Immunol, vol.18, pp.225-231, 2008. ,
Combination of omalizumab and bee venom immunotherapy: does it work?, Asia Pac Allergy, vol.8, p.2, 2018. ,
Combining anti-IgE with oral immunotherapy, Pediatr Allergy Immunol, vol.28, pp.619-646, 2017. ,
Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy, J Allergy Clin Immunol, vol.140, pp.1043-53, 2017. ,
Safety of ultrarush venom immunotherapy: comparison between children and adults, J Investig Allergol Clin Immunol, vol.26, pp.40-47, 2016. ,